Epiphany Dato

Statistics

Publications

Citations

180

H-Index

Active since

2017

Affiliations

Secretaría Nacional de Ciencia, Tecnología e Innovación(Current)

Takeda (Switzerland)

Takeda (Singapore)

Hospital del Niño

De La Salle University

Epiphany Dato is an author at Secretaría Nacional de Ciencia, Tecnología e Innovación specializing in vaccine safety, pediatric immunization, and immunization.

Publications per year

2017–2020

Publications

Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial

Vianney Tricou, Xavier Sáez‐Llorens, Delia Yu et al. · The Lancet · 2020 · 105 citations

Veterinary Medicine, Immunology, Pediatrics +14

Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study

Xavier Sáez‐Llorens, Vianney Tricou, Delia Yu et al. · The Lancet Infectious Diseases · 2017 · 75 citations

Medicine, Immunology, Pediatrics +16

1–2 of 2